e-learning
resources
Copenhagen 2005
Tuesday 20.09.2005
Biology of tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The status of populations of cell-mediated lung immunity effectors after chemotherapy of experimental MDR tuberculosis
L. K. Surkova, M. I. Dziusmikeyeva, N. S. Shpakovskaya, A. M. Zalutskaya (Minsk, Belarus)
Source:
Annual Congress 2005 - Biology of tuberculosis
Session:
Biology of tuberculosis
Session type:
Thematic Poster Session
Number:
4151
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. K. Surkova, M. I. Dziusmikeyeva, N. S. Shpakovskaya, A. M. Zalutskaya (Minsk, Belarus). The status of populations of cell-mediated lung immunity effectors after chemotherapy of experimental MDR tuberculosis. Eur Respir J 2005; 26: Suppl. 49, 4151
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Related content which might interest you:
Monitoring T-cell immunity towards
M. tuberculosis
: impaired specific immunocompetence in patients receiving high levels of immunosuppressive drugs
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008
Comparison of effector T-cell responses in patients with active TB disease compared to latent TB infection
Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease
Year: 2007
In vitro
immune response to
Mycobacterium tuberculosis
antigens
Source: Eur Respir J 2005; 26: Suppl. 49, 22s
Year: 2005
Does BCG revaccination lead to enhanced protective immunity against tuberculosis? A study using surrogate markers
Source: Annual Congress 2005 - Epidemiology and control of tuberculosis and LTBI
Year: 2005
Cytomegalovirus-specific cell-mediated immunity after prophylaxis predicts late-onset infection in lung transplantation
Source: Virtual Congress 2020 – Clinical management of lung transplant recipients
Year: 2020
IgG-mediated humoral immune response against different mycobacterial antigens in tuberculosis (TB) and mycobacterial infections other than tuberculosis (MOTT)
Source: Eur Respir J 2001; 18: Suppl. 33, 307s
Year: 2001
The role of increasing TIM3 on T cells in patients with nontuberculous mycobacterial lung disease: from immune cell dysfunction to clinical severity
Source: Virtual Congress 2021 – Advances in the diagnosis of tuberculosis, multidrug-resistant tuberculosis and nontuberculous mycobacterial disease
Year: 2021
T-cell response against tuberculosis antigens is dependent on the level of immunosuppression in renal and lung transplant patients
Source: Eur Respir J 2006; 28: Suppl. 50, 344s
Year: 2006
From ineffective tumor immune response to immunomodulation in lung cancer
Source: ERS Research Seminar 2017 – Immunotherapy: a new standard of care in thoracic malignancies?
Year: 2017
Mucosal immunity and novel tuberculosis vaccine strategies: route of immunisation-determined T-cell homing to restricted lung mucosal compartments
Source: Eur Respir Rev 2015; 24: 356-360
Year: 2015
Role of adaptive immunity in clinical variability of active tuberculosis patients
Source: Virtual Congress 2021 – Novel imaging analysis methodologies in diffuse lung diseases
Year: 2021
How infections can modify lung immunity
Source: Guideline 2001
Year: 2001
How infections can modify lung immunity
Source: Eur Respir J 2001; 18: 442-443
Year: 2001
Induction of M. tuberculosis (MTB) drug resistance (DR) mutations in HIV-infected hosts and pathways of further spread of the evolutionary successful drug-resistant MTB clonal lines
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
Do antimicrobial peptides shape the adaptive immune response?
Source: Annual Congress 2005 - Interaction between innate and adaptive immunity in lung disease
Year: 2005
Tuberculosis treatment effect on T-cell interferon-γ responses to Mycobacterium tuberculosis-specific antigens
Source: Eur Respir J 2010; 36: 355
Year: 2010
Radiological findings of inactive tuberculosis do not correlate with
M. tuberculosis
-specific T-cell immunity in high-risk patients
Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease
Year: 2008
Organised local immune response in the lungs of patients with tuberculosis
Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Year: 2009
LSC Abstract – The host genetic background impacts on pseudomonas aeruginosa-induced T cell responses and individual susceptibility/resistance to respiratory infection
Source: International Congress 2015 – Respiratory infections: from basic science to clinical issues
Year: 2015
Role of cytokines in regulation of inflammatory and protective reactions in progression of pulmonary MDR tuberculosis
Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept